Breaking News Instant updates and real-time market news.

2023-01-17 09:12:08 ASRT Assertio Holdings $4.19 / -0.06 (-1.41%) 09:12 01/17/23 01/17 09:12 01/17/23 09:12	Assertio provides the LGS Foundation $100,000 educational grant Assertio Holdings announced that it has provided the LGS Foundation a $100,000 educational grant to assist in efforts to raise awareness of LGS and provide educational materials to the LGS community. In October, Assertio acquired an exclusive license for SYMPAZAN or clobazam oral film CIV, which is approved by the U.S. Food and Drug Administration FDA for the adjunctive treatment of seizures associated with LGS in patients two years of age or older.According to the LGS Foundation, Lennox-Gastaut Syndrome or LGS is a severe epilepsy syndrome. LGS is a rare disease, about 50,000 people in the United States have LGS. It is generally diagnosed between the ages of 3 and 5, but some people aren't correctly diagnosed until much later. People with LGS may have many different types of seizures, and the condition can be complex to manage. Some people with LGS also experience cognitive and behavioral challenges.

2023-01-17 09:12:08

ASRT

Assertio Holdings

$4.19 / -0.06 (-1.41%)

09:12

01/17/23

01/17

09:12

01/17/23

09:12

Assertio provides the LGS Foundation $100,000 educational grant

Assertio Holdings announced that it has provided the LGS Foundation a $100,000 educational grant to assist in efforts to raise awareness of LGS and provide educational materials to the LGS community. In October, Assertio acquired an exclusive license for SYMPAZAN or clobazam oral film CIV, which is approved by the U.S. Food and Drug Administration FDA for the adjunctive treatment of seizures associated with LGS in patients two years of age or older.According to the LGS Foundation, Lennox-Gastaut Syndrome or LGS is a severe epilepsy syndrome. LGS is a rare disease, about 50,000 people in the United States have LGS. It is generally diagnosed between the ages of 3 and 5, but some people aren't correctly diagnosed until much later. People with LGS may have many different types of seizures, and the condition can be complex to manage. Some people with LGS also experience cognitive and behavioral challenges.

OTHER BREAKING NEWS FROM THE FLY

Initiation	Axonics assumed with an Overweight at Morgan Stanley » 06:58 05/30/23 05/30 06:58 05/30/23 06:58 AXNX Axonics $48.52 / -1.03 (-2.08%) Morgan Stanley assumed… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return on Jun 2nd, 06:58 Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Events AXNX Axonics $48.52 / -1.03 (-2.08%) 04/24/23 Axonics acquired assets of Radian, terms not disclosed 01/31/23 Axonics receives FDA approval for rechargeable sacral neuromodulation system 12/13/22 Axonics announces Health Canada approval of R20 neurostimulator AXNX Axonics $48.52 / -1.03 (-2.08%) 05/23/23 CL King Axonics initiated with Buy on 'underpenetrated markets' at CL King 05/23/23 CL King Axonics initiated with a Buy at CL King 05/02/23 Needham Axonics price target raised to $73 from $71 at Needham 04/17/23 Truist Axonics price target lowered to $73 from $82 at Truist AXNX Axonics $48.52 / -1.03 (-2.08%) 05/01/23 Axonics raises FY23 revenue view to $348M from $324M, consensus $347.8M 05/01/23 Axonics reports Q1 EPS (19c), consensus (29c) 03/01/23 Axonics backs FY23 revenue view of $342M, consensus $336.4M 03/01/23 Axonics reports Q4 EPS 1c, consensus (24c) 03 Aug AXNX Axonics $48.52 / -1.03 (-2.08%) 05/23/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 05/01/23 Fly Intel: After-Hours Movers 03/24/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 01/11/23 What You Missed On Wall Street On Wednesday 06/26/23 Axonics Inc
Recommendations	Insperity price target lowered to $120 from $131 at Baird » 06:57 05/30/23 05/30 06:57 05/30/23 06:57 NSP Insperity $110.43 / +0.2 (+0.18%) Baird analyst Mark Marcon… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return on Jun 2nd, 06:57 Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events NSP Insperity $110.43 / +0.2 (+0.18%) 05/24/23 Insperity announces 10% dividend increase to 57c per share 04/24/23 Insperity falls -7.4% 02/16/23 Insperity VP Herinks ells 5,000 shares of company stock NSP Insperity $110.43 / +0.2 (+0.18%) 04/27/23 Roth MKM Insperity price target raised to $147 from $144 at Roth MKM 04/24/23 Truist Insperity cut to Hold at Truist amid softening white collar labor trends 04/24/23 Truist Insperity downgraded to Hold from Buy at Truist 04/24/23 Truist Insperity downgraded to Hold from Buy at Truist NSP Insperity $110.43 / +0.2 (+0.18%) 04/26/23 Insperity sees FY23 EPS $5.62 - $6.39, consensus $5.66 04/26/23 Insperity sees Q2 EPS $1.16- $1.32, consensus $1.17 04/26/23 Insperity reports Q1 EPS $2.67, consensus $2.48 02/09/23 Insperity sees FY23 EPS $5.24-$6.30, consensus $5.32 NSP Insperity $110.43 / +0.2 (+0.18%) 04/24/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 06/13/23 Business Services Bus Tour
Initiation	Sight Sciences assumed with an Overweight at Morgan Stanley » 06:57 05/30/23 05/30 06:57 05/30/23 06:57 SGHT Sight Sciences $9.26 / +0.24 (+2.66%) Morgan Stanley analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return on Jun 2nd, 06:57 Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events SGHT Sight Sciences $9.26 / +0.24 (+2.66%) 05/23/23 Sight Sciences announces publication of two-year results of ROMEO study 05/07/23 Sight Sciences announces 12-month results from MIGS comparative analysis of RWD 04/03/23 Sight Sciences appoints Alison Bauerlein CFO 03/30/23 Sight Sciences defeats invalidity challenges filed by Alcon, Ivantis SGHT Sight Sciences $9.26 / +0.24 (+2.66%) 01/06/23 Stifel Stifel upgrades Sight Sciences to Buy on potential 2023 upside 01/06/23 Stifel Sight Sciences upgraded to Buy from Hold at Stifel 12/12/22 Citi Sight Sciences price target raised to $15 from $10 at Citi 10/12/22 Piper Sandler CMS proposal a positive for Med Tech sector, says Piper Sandler SGHT Sight Sciences $9.26 / +0.24 (+2.66%) 03/13/23 Sight Sciences sees FY23 revenue $ $89M-$94M, consensus $91.22M 03/13/23 Sight Sciences reports Q4 EPS (35c), consensus (42c) 01/09/23 Sight Sciences sees FY22 revenue $71.2M-$71.4M, consensus $70.93M 01/09/23 Sight Sciences sees Q4 revenue $20.4M-$20.6M , consensus $20.12M SGHT Sight Sciences $9.26 / +0.24 (+2.66%) 01/09/23 Fly Intel: After-Hours Movers 06/08/23 Sight Sciences, Inc.
Initiation	Insulet assumed with an Equal Weight at Morgan Stanley » 06:56 05/30/23 05/30 06:56 05/30/23 06:56 PODD Insulet $272.56 / -4.225 (-1.53%) Morgan Stanley assumed… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return on Jun 2nd, 06:56 Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly PODD Insulet $272.56 / -4.225 (-1.53%) 05/04/23 Insulet names Eric Benjamin CPXO, Mark Field CTO 04/25/23 Insulet announces FDA approval of Omnipod GO 04/21/23 Tandem Diabetes down 5% after FDA approves Medtronic's MiniMed 780G 03/15/23 Insulet to replace SVB Financial in S&P 500 at open on 3/15 PODD Insulet $272.56 / -4.225 (-1.53%) 05/08/23 Barclays Insulet price target raised to $329 from $292 at Barclays 05/05/23 UBS Insulet price target raised to $360 from $328 at UBS 05/05/23 Piper Sandler Insulet price target raised to $360 from $340 at Piper Sandler 05/05/23 Baird Insulet price target raised to $370 from $350 at Baird PODD Insulet $272.56 / -4.225 (-1.53%) 05/04/23 Insulet raises FY23 revenue growth view to 18%-22% from 14%-19% 05/04/23 Insulet sees Q2 revenue growth of 27%-30% 05/04/23 Insulet reports Q1 EPS 34c, consensus 11c 02/23/23 Insulet sees FY23 revenue growth 14%-19%, consensus $1.47B PODD Insulet $272.56 / -4.225 (-1.53%) 02/22/23 Apple hits breakthroughs in glucose monitoring project, Bloomberg reports PODD Insulet $272.56 / -4.225 (-1.53%) 05/05/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 03/29/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 02/23/23 Fly Intel: After-Hours Movers 02/22/23 Diabetes management stocks slide on report of tech giant's breakthroughs
Initiation	DexCom assumed with an Equal Weight at Morgan Stanley » 06:56 05/30/23 05/30 06:56 05/30/23 06:56 DXCM DexCom $115.06 / +0.475 (+0.41%) Morgan Stanley analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return on Jun 2nd, 06:56 Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options DXCM DexCom $115.06 / +0.475 (+0.41%) 04/17/23 DexCom commends expansion of CGM Medicare to diabetics using all insulin types 03/21/23 DexCom announces expanded coverage for G6 CGM System in Manitoba 03/13/23 DexCom has no material exposure to developments at Silicon Valley Bank 03/06/23 DexCom down more than 7% after FDA gives nod to Abbott CGM sensors DXCM DexCom $115.06 / +0.475 (+0.41%) 05/01/23 Barclays DexCom price target raised to $115 from $110 at Barclays 04/28/23 Stifel DexCom price target raised to $140 from $130 at Stifel 04/28/23 UBS DexCom price target raised to $150 from $142 at UBS 04/28/23 BTIG DexCom price target raised to $134 from $132 at BTIG DXCM DexCom $115.06 / +0.475 (+0.41%) 04/27/23 DexCom sees FY23 revenue $3.40B-$3.52B, consensus $3.47B 04/27/23 DexCom reports Q1 EPS 17c, consensus 15c 04/27/23 Notable companies reporting after market close 02/09/23 DexCom sees FY23 revenue of $3.35B-$3.49B, consensus $3.47B DXCM DexCom $115.06 / +0.475 (+0.41%) 02/22/23 Apple hits breakthroughs in glucose monitoring project, Bloomberg reports DXCM DexCom $115.06 / +0.475 (+0.41%) 04/27/23 Fly Intel: After-Hours Movers 04/03/23 Fly Insider: Kohl's, 89Bio among week's notable insider trades 03/29/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 02/22/23 Diabetes management stocks slide on report of tech giant's breakthroughs 00:00 Today DexCom DXCM DexCom $115.06 / +0.475 (+0.41%) 03/06/23 DexCom put volume heavy and directionally bearish 03/02/23 Early notable gainers among liquid option names on March 2nd 02/10/23 Early notable gainers among liquid option names on February 10th 02/09/23 DexCom options imply 6.0% move in share price post-earnings
Initiation	TransMedics assumed with an Equal Weight at Morgan Stanley » 06:55 05/30/23 05/30 06:55 05/30/23 06:55 TMDX TransMedics / + Morgan Stanley analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return on Jun 2nd, 06:55 Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly TMDX TransMedics / + 02/22/23 TransMedics jumps 14% to $73.72 after Q4 results, above-consensus guidance 01/25/23 TransMedics CEO Hassanein sells $801K in company shares TMDX TransMedics / + 05/18/23 Canaccord TransMedics price target lowered to $86 from $91 at Canaccord 05/02/23 Oppenheimer TransMedics price target raised to $90 from $85 at Oppenheimer 05/01/23 Canaccord TransMedics price target raised to $91 from $78 at Canaccord 02/23/23 Canaccord TransMedics price target raised to $78 from $68 at Canaccord TMDX TransMedics / + 05/01/23 TransMedics raises FY23 revenue view to $160M-$170M from $138M-$145M 05/01/23 TransMedics reports Q1 EPS (8c), consensus (25c) 02/22/23 TransMedics sees 2023 revenue $$138M-$145M, consensus $134.71M 02/22/23 TransMedics reports Q4 EPS (21c), consensus (30c) 05 Aug TMDX TransMedics / + 02/22/23 Fly Intel: After-Hours Movers
Recommendations	Hibbett price target lowered to $50 from $70 at Baird » 06:55 05/30/23 05/30 06:55 05/30/23 06:55 HIBB Hibbett $39.20 / -4.9 (-11.11%) Baird lowered the… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return on Jun 2nd, 06:55 Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events HIBB Hibbett $39.20 / -4.9 (-11.11%) 05/26/23 Hibbett CEO says 'our consumers are facing a number of headwinds' 03/03/23 Hibbett sees FY24 CapEx $60M-$70M 03/03/23 Hibbett sees FY24 gross margin down 20-30 bps vs. FY23 03/03/23 Hibbett CEO sees 'several headwinds' in FY24 HIBB Hibbett $39.20 / -4.9 (-11.11%) 05/26/23 Baird Hibbett price target lowered to $50 from $80 at Baird 05/26/23 BofA Hibbett downgraded to Underperform from Buy at BofA 05/26/23 Williams Trading Hibbett cut to Sell at Williams Trading after 'far worse' than expected outlook 05/26/23 Williams Trading Hibbett downgraded to Sell from Hold at Williams Trading HIBB Hibbett $39.20 / -4.9 (-11.11%) 05/26/23 Hibbett cuts FY24 EPS view to $7.00-$7.75 from $9.50-$10.0, consensus $9.14 05/26/23 Hibbett reports Q1 EPS $2.74, consensus $3.04 03/03/23 Hibbett sees FY24 EPS $9.50-$10.0, consensus $10.40 03/03/23 Hibbett reports Q4 EPS $2.91, consensus $2.94 HIBB Hibbett $39.20 / -4.9 (-11.11%) 05/26/23 What You Missed On Wall Street On Friday 05/26/23 What You Missed On Wall Street This Morning 05/26/23 Fly Intel: Pre-market Movers 03/14/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 05/31/23 Hibbett 06/07/23 Hibbett Inc
Initiation	Teleflex assumed with an Equal Weight at Morgan Stanley » 06:54 05/30/23 05/30 06:54 05/30/23 06:54 TFX Teleflex $232.54 / -0.87 (-0.37%) Morgan Stanley analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return on Jun 2nd, 06:54 Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events TFX Teleflex $232.54 / -0.87 (-0.37%) 03/29/23 Teleflex signs supply agreement for staple line reinforcement material 03/13/23 Teleflex announces research data on the UroLift System 02/22/23 Teleflex announces key milestones in the release of two new catheters 02/07/23 Teleflex awarded GPO agreement with Premier TFX Teleflex $232.54 / -0.87 (-0.37%) 04/26/23 Wolfe Research Teleflex downgraded to Peer Perform from Outperform at Wolfe Research 04/18/23 Mizuho Teleflex price target raised to $250 from $220 at Mizuho 04/17/23 Truist Teleflex price target raised to $264 from $250 at Truist 12/28/22 Stephens Teleflex price target raised to $295 from $280 at Stephens TFX Teleflex $232.54 / -0.87 (-0.37%) 05/04/23 Teleflex backs FY23 adjusted EPS view $13.00-$13.60, consensus $13.29 05/04/23 Teleflex reports Q1 adjusted EPS $3.09, consensus $2.97 02/23/23 Teleflex sees 2023 adjusted EPS $13.00-$13.60, consensus $13.49 02/23/23 Teleflex reports Q4 adjusted EPS $3.52, consensus $3.44 06/07/23 Teleflex 06/08/23 Teleflex 06/09/23 Teleflex
Initiation	Edwards Lifesciences assumed with an Overweight at Morgan Stanley » 06:54 05/30/23 05/30 06:54 05/30/23 06:54 EW Edwards Lifesciences $82.00 / +0.32 (+0.39%) Morgan Stanley analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return on Jun 2nd, 06:54 Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events Options EW Edwards Lifesciences $82.00 / +0.32 (+0.39%) 12/08/22 Edwards Lifesciences CEO Michael Mussallem to retire, Bernard Zovighian succeeds EW Edwards Lifesciences $82.00 / +0.32 (+0.39%) 05/18/23 Truist Edwards Lifesciences price target raised to $101 from $97 at Truist 04/28/23 Barclays Edwards Lifesciences price target raised to $102 from $94 at Barclays 04/27/23 Wells Fargo Edwards Lifesciences price target raised to $90 from $78 at Wells Fargo 04/27/23 Piper Sandler Edwards Lifesciences price target raised to $83 from $80 at Piper Sandler EW Edwards Lifesciences $82.00 / +0.32 (+0.39%) 04/26/23 Edwards Lifesciences raises FY23 adj. EPS view to 2.48-$2.60 from $2.45-$2.60 04/26/23 Edwards Lifesciences sees Q2 adjusted EPS 62c-68c, consensus 63c 04/26/23 Edwards Lifesciences reports Q1 adjusted EPS 62c, consensus 61c 04/26/23 Notable companies reporting after market close EW Edwards Lifesciences $82.00 / +0.32 (+0.39%) 04/26/23 Fly Intel: After-Hours Movers 03/08/23 What You Missed On Wall Street On Wednesday 03/08/23 What You Missed On Wall Street This Morning 03/08/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 06/06/23 Edwards Lifesciences EW Edwards Lifesciences $82.00 / +0.32 (+0.39%) 02/01/23 Early notable gainers among liquid option names on February 1st 01/31/23 Edwards Lifesciences options imply 5.3% move in share price post-earnings 12/05/22 Edwards Lifesciences call volume above normal and directionally bullish
Initiation	ShockWave Medical assumed with an Equal Weight at Morgan Stanley » 06:53 05/30/23 05/30 06:53 05/30/23 06:53 SWAV ShockWave Medical / + Morgan Stanley assumed… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return on Jun 2nd, 06:53 Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events SWAV ShockWave Medical / + 05/17/23 ShockWave Medical appoints Ballinger to board of directors 05/15/23 ShockWave announces full commercial availability of Shockwave C2+ Coronary IVL 04/21/23 Boston Scientific drops 2% after Bloomberg says exploring ShockWave deal 04/21/23 ShockWave Medical jumps 13% to $293.97 after Bloomberg report SWAV ShockWave Medical / + 05/12/23 Piper Sandler Piper continues to view ShockWave Medical as 'highly coveted asset' 05/09/23 Deutsche Bank ShockWave Medical price target raised to $310 from $285 at Deutsche Bank 05/09/23 Needham ShockWave Medical price target raised to $325 from $283 at Needham 05/09/23 Piper Sandler ShockWave Medical price target raised to $315 from $280 at Piper Sandler SWAV ShockWave Medical / + 05/08/23 ShockWave Medical reports Q1 EPS $1.03, consensus 81c 02/17/23 ShockWave Medical sees FY23 revenue $660M-$680M, consensus $658.58M 02/16/23 ShockWave Medical reports Q4 EPS $3.71, consensus $1.00 01/17/23 ShockWave Medical sees 2023 revenue $660M-$680M, consensus $639.85M SWAV ShockWave Medical / + 05/10/23 New suitors showing interest in ShockWave Medical, Street Insider says 05/08/23 ShockWave down 6% after blog says Boston Scientific talks have 'fallen apart' 05/08/23 ShockWave Medical talks with Boston Scientific broke down, Street Insider says 04/21/23 Boston Scientific exploring deal to acquire ShockWave, Bloomberg reports SWAV ShockWave Medical / + 05/08/23 What You Missed On Wall Street On Monday 05/08/23 What You Missed On Wall Street This Morning 04/21/23 What You Missed On Wall Street On Friday 04/21/23 What You Missed On Wall Street This Morning 08/07/23 ShockWave Medical - SWAV 06/13/23 ShockWave Medical, Inc.

Recommendations	Lincoln Electric price target raised to $200 from $184 at Baird » 06:53 05/30/23 05/30 06:53 05/30/23 06:53 LECO Lincoln Electric $173.52 / +2.76 (+1.62%) Baird analyst Mircea… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return on Jun 2nd, 06:53 Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events LECO Lincoln Electric $173.52 / +2.76 (+1.62%) 05/03/23 Lincoln Electric acquires Powermig Automacao e Soldagem, terms undisclosed LECO Lincoln Electric $173.52 / +2.76 (+1.62%) 05/02/23 Barclays Lincoln Electric price target raised to $185 from $145 at Barclays 04/28/23 Oppenheimer Lincoln Electric price target raised to $180 from $177 at Oppenheimer 04/27/23 Baird Lincoln Electric price target raised to $184 from $180 at Baird 04/17/23 Stifel Lincoln Electric price target raised to $176 from $173 at Stifel LECO Lincoln Electric $173.52 / +2.76 (+1.62%) 04/27/23 Lincoln Electric reports Q1 adjusted EPS $2.13, consensus $2.05 02/21/23 Lincoln Electric reports Q4 adjusted EPS $1.94, consensus $1.90 00:00 Today Industrials & Basic Materials Conference
Initiation	Boston Scientific assumed with an Overweight at Morgan Stanley » 06:52 05/30/23 05/30 06:52 05/30/23 06:52 BSX Boston Scientific $51.05 / -0.49 (-0.95%) Morgan Stanley analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return on Jun 2nd, 06:52 Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options BSX Boston Scientific $51.05 / -0.49 (-0.95%) 05/21/23 Boston Scientific presents data at Hearth Rhythm 2023 05/17/23 Boston Scientific VP Fitzgerald sells $3.4M in company shares 05/15/23 Standard BioTools appoints Jeffrey Black as Chief Financial Officer 04/21/23 Boston Scientific drops 2% after Bloomberg says exploring ShockWave deal BSX Boston Scientific $51.05 / -0.49 (-0.95%) 05/16/23 BofA BofA says Boston Scientific Watchman label update important, ups target 04/27/23 Stifel Boston Scientific price target raised to $58 from $52 at Stifel 04/27/23 RBC Capital Boston Scientific price target raised to $56 from $53 at RBC Capital 04/27/23 Deutsche Bank Boston Scientific price target raised to $55 from $45 at Deutsche Bank BSX Boston Scientific $51.05 / -0.49 (-0.95%) 04/26/23 Boston Scientific raises FY23 adjusted EPS view to $1.90-$1.96 from $1.86-$1.93 04/26/23 Boston Scientific sees Q2 EPS 48c-50c, consensus 48c 04/26/23 Boston Scientific reports Q1 adjusted EPS 47c, consensus 43c 04/25/23 Notable companies reporting before tomorrow's open BSX Boston Scientific $51.05 / -0.49 (-0.95%) 05/24/23 Boston Scientific abandons $230M deal for majority M.I. Tech stake, STAT says 05/10/23 New suitors showing interest in ShockWave Medical, Street Insider says 05/08/23 ShockWave down 6% after blog says Boston Scientific talks have 'fallen apart' 05/08/23 ShockWave Medical talks with Boston Scientific broke down, Street Insider says BSX Boston Scientific $51.05 / -0.49 (-0.95%) 05/25/23 What You Missed On Wall Street On Thursday 05/25/23 What You Missed On Wall Street This Morning 05/08/23 What You Missed On Wall Street On Monday 05/08/23 What You Missed On Wall Street This Morning BSX Boston Scientific $51.05 / -0.49 (-0.95%) 04/25/23 Boston Scientific call volume above normal and directionally bullish 04/24/23 Boston Scientific put volume heavy and directionally bearish 04/21/23 Boston Scientific put volume heavy and directionally bearish 01/11/23 Boston Scientific put volume heavy and directionally bearish
Initiation	Bausch + Lomb assumed with an Equal Weight at Morgan Stanley » 06:52 05/30/23 05/30 06:52 05/30/23 06:52 BLCO Bausch + Lomb $17.92 / -0.58 (-3.14%) Morgan Stanley assumed… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return on Jun 2nd, 06:52 Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly BLCO Bausch + Lomb $17.92 / -0.58 (-3.14%) 05/18/23 Bausch + Lomb and Novaliq announce FDA approval of Miebo 03/22/23 Bausch + Lomb, Novaliq announce publication of Phase 3 data on NOV03 02/15/23 Bausch + Lomb rises 12.8% 02/15/23 Bausch + Lomb names Brent Saunders as CEO, succeeding Joseph Papa BLCO Bausch + Lomb $17.92 / -0.58 (-3.14%) 05/22/23 Jefferies Bausch Health price target raised to $9.50 from $7 at Jefferies 05/19/23 H.C. Wainwright Bausch + Lomb price target raised to $22 from $19 at H.C. Wainwright 05/18/23 Wells Fargo Bausch + Lomb has 'significant opportunity' with Miebo, says Wells Fargo 05/17/23 RBC Capital District Court ruling positive for Bausch Health and Bausch + Lomb, says RBC BLCO Bausch + Lomb $17.92 / -0.58 (-3.14%) 05/03/23 Bausch + Lomb sees FY23 revenue $3.9B-$3.95B, consensus $5.32B 05/03/23 Bausch + Lomb Q1 adjusted EPS 10c vs. 24c last year 02/22/23 Bausch + Lomb reports Q4 adjusted EPS 23c vs. 35c a year ago BLCO Bausch + Lomb $17.92 / -0.58 (-3.14%) 12/21/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
Initiation	Alcon assumed with an Equal Weight at Morgan Stanley » 06:51 05/30/23 05/30 06:51 05/30/23 06:51 ALC Alcon $79.06 / +0.78 (+1.00%) Morgan Stanley analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return on Jun 2nd, 06:51 Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly ALC Alcon $79.06 / +0.78 (+1.00%) 05/22/23 Lifecore enters into $150M new financing with Alcon 05/01/23 Alcon announces presence at ASCRS 2023 03/30/23 Sight Sciences defeats invalidity challenges filed by Alcon, Ivantis 02/13/23 Alcon to pay $199M in settlement agreement with J&J Surgical Vision ALC Alcon $79.06 / +0.78 (+1.00%) 05/24/23 Barrington Lifecore price target raised to $10 from $8 at Barrington 05/23/23 Stephens Lifecore 'now a much cleaner story,' says Stephens 05/11/23 JPMorgan Alcon price target raised to CHF 71 from CHF 63.80 at JPMorgan 05/11/23 Mizuho Alcon price target raised to $95 from $85 at Mizuho ALC Alcon $79.06 / +0.78 (+1.00%) 05/09/23 Alcon backs FY23 EPS view of $2.55-$2.65, consensus $2.59 05/09/23 Alcon reports Q1 EPS 70c, consensus 60c 02/27/23 Alcon sees FY23 EPS $2.55-$2.65, consensus $2.52 02/27/23 Alcon reports Q4 EPS 42c, consensus 42c ALC Alcon $79.06 / +0.78 (+1.00%) 05/10/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 02/27/23 Fly Intel: After-Hours Movers 12/22/22 What You Missed On Wall Street On Thursday 12/22/22 What You Missed On Wall Street This Morning
Recommendations	Google AI chip orders accelerating at Broadcom, says JPMorgan » 06:50 05/30/23 05/30 06:50 05/30/23 06:50 AVGO Broadcom $812.72 / +84.07 (+11.54%) , GOOG Alphabet $125.37 / +1.04 (+0.84%) , GOOGL Alphabet $124.62 / +1.14 (+0.92%) , META Meta Platforms $262.01 / +9.33 (+3.69%) JPMorgan analyst Harlan… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return on Jun 2nd, 06:50 Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options AVGO GOOG GOOGL META AVGO Broadcom $812.72 / +84.07 (+11.54%) 05/23/23 Broadcom up 2% after Apple announces 'multibillion-dollar' supply deal 05/23/23 Broadcom reports two separate multi-year statements of work with Apple 05/23/23 Apple reports 'multibillion-dollar' deal with Broadcom for U.S.-made components 04/18/23 Broadcom announces delivery of Jericho3-AI GOOG Alphabet $125.37 / +1.04 (+0.84%) 05/29/23 Fly Intel: Top five weekend stock stories 05/29/23 Nvidia announces DGX GH200 AI supercomputer 05/25/23 Google starts access to new generative AI capacity in Search 05/24/23 Pershing Square: In very early days of AI development GOOGL Alphabet $124.62 / +1.14 (+0.92%) 05/29/23 Fly Intel: Top five weekend stock stories 05/29/23 Nvidia announces DGX GH200 AI supercomputer 05/25/23 Google starts access to new generative AI capacity in Search 05/24/23 Pershing Square: In very early days of AI development META Meta Platforms $262.01 / +9.33 (+3.69%) 05/29/23 Fly Intel: Top five weekend stock stories 05/29/23 Nvidia announces DGX GH200 AI supercomputer 05/23/23 Shutterstock to acquire GIPHY from Meta Platforms for $53M 05/23/23 Shutterstock to acquire GIPHY from Meta Platforms for $53M AVGO GOOG GOOGL META AVGO Broadcom $812.72 / +84.07 (+11.54%) 06:11 Today KeyBanc Broadcom price target raised to $820 from $720 at KeyBanc 05/26/23 Oppenheimer Broadcom price target raised to $800 from $720 at Oppenheimer 05/25/23 BofA Nvidia price target raised to $450 from $340 at BofA 05/25/23 Susquehanna Broadcom price target raised to $785 from $690 at Susquehanna GOOG Alphabet $125.37 / +1.04 (+0.84%) 06:11 Today KeyBanc Broadcom price target raised to $820 from $720 at KeyBanc 05/24/23 BofA Google's three pillars 'still upright' despite Bing in ChatGPT, says BofA 05/24/23 BofA Partnership with Waymo 'positive for Uber on several fronts,' says BofA 05/23/23 Jefferies Alphabet price target raised to $150 from $130 at Jefferies GOOGL Alphabet $124.62 / +1.14 (+0.92%) 06:11 Today KeyBanc Broadcom price target raised to $820 from $720 at KeyBanc 05/24/23 BofA Google's three pillars 'still upright' despite Bing in ChatGPT, says BofA 05/24/23 BofA Partnership with Waymo 'positive for Uber on several fronts,' says BofA 05/23/23 Jefferies Alphabet price target raised to $150 from $130 at Jefferies META Meta Platforms $262.01 / +9.33 (+3.69%) 05/23/23 Piper Sandler Meta's AI initiatives could drive revenue recapture, says Piper Sandler 05/23/23 Citi Citi sees minimal risk to Meta Platforms after E.U. data fine 05/22/23 Evercore ISI Meta, Spotify, Zillow removed from 'Tactical Outperform' list at Evercore ISI 05/19/23 Roth MKM Meta Platforms' capex may decline in 2023-2024, says Roth MKM AVGO GOOG GOOGL META AVGO Broadcom $812.72 / +84.07 (+11.54%) 03/02/23 Broadcom sees Q2 revenue approximately $8.7B, consensus $8.59B 03/02/23 Broadcom reports Q1 adjusted EPS $10.33, consensus $10.10 03/02/23 VMware reports Q4 EPS $2.13, consensus $1.92 03/02/23 Notable companies reporting after market close GOOG Alphabet $125.37 / +1.04 (+0.84%) 04/25/23 Alphabet reports Q1 EPS $1.17, consensus $1.07 04/25/23 Alphabet reports Q1 Google Cloud revenue $7.45B vs. $5.82B last year 04/25/23 Alphabet reports Q1 EPS $1.17, consensus $1.07 04/25/23 Notable companies reporting after market close GOOGL Alphabet $124.62 / +1.14 (+0.92%) 04/25/23 Alphabet reports Q1 EPS $1.17, consensus $1.07 04/25/23 Alphabet reports Q1 Google Cloud revenue $7.45B vs. $5.82B last year 04/25/23 Alphabet reports Q1 EPS $1.17, consensus $1.07 04/25/23 Notable companies reporting after market close META Meta Platforms $262.01 / +9.33 (+3.69%) 05/21/23 Fly Intel: Top five weekend stock stories 04/26/23 Meta Platforms sees Q2 revenue $29.5B-$32B, consensus $29.48B 04/26/23 Meta Platforms reports Q1 EPS $2.20, consensus $2.53 04/26/23 Notable companies reporting after market close AVGO GOOG GOOGL META AVGO Broadcom $812.72 / +84.07 (+11.54%) 03/04/23 Boom time for farmers can last, Deere stands to benefit, Barron's says 02/27/23 Broadcom set to receive EU warning over VMware deal, Reuters reports 02/13/23 Democrats want tighter limit on stock buybacks in chip subsidies, Bloomberg says 02/03/23 Broadcom CEO Tan plans to seek more acquisitions after VMware, FT reports GOOG Alphabet $125.37 / +1.04 (+0.84%) 05/26/23 Google ordered to pay Sonos $32.5M in patent infringement case, Verge says 05/25/23 YouTube to shut down Stories on June 26 amid focus on Shorts, TechCrunch says 05/24/23 DoorDash sued in $1B lawsuit for charging iPhone users more, NY Post reports 05/23/23 White House wants workers opinion on employers use of AI, Reuters reports GOOGL Alphabet $124.62 / +1.14 (+0.92%) 05/26/23 Google ordered to pay Sonos $32.5M in patent infringement case, Verge says 05/25/23 YouTube to shut down Stories on June 26 amid focus on Shorts, TechCrunch says 05/24/23 DoorDash sued in $1B lawsuit for charging iPhone users more, NY Post reports 05/23/23 Google to experiment with ads appearing directly in AI chatbot, TechCrunch says META Meta Platforms $262.01 / +9.33 (+3.69%) 05/25/23 Meta Platforms completes previously announced job cuts, Bloomberg reports 05/24/23 Meta Platforms starts next round of layoffs, CNBC reports 05/24/23 EU court dismisses Meta's challenge to hand over data, Bloomberg reports 05/23/23 White House wants workers opinion on employers use of AI, Reuters reports AVGO GOOG GOOGL META AVGO Broadcom $812.72 / +84.07 (+11.54%) 05/23/23 What You Missed On Wall Street On Tuesday 05/23/23 What You Missed On Wall Street This Morning 04/13/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 03/03/23 What You Missed On Wall Street On Friday GOOG Alphabet $125.37 / +1.04 (+0.84%) 05/24/23 #SocialStocks: Meta fined EUR 1.2B in Ireland for infringing on data laws 05/17/23 #SocialStocks: Tech companies seek employees abroad after hiring freeze 05/15/23 What You Missed On Wall Street On Monday 05/15/23 What You Missed On Wall Street This Morning GOOGL Alphabet $124.62 / +1.14 (+0.92%) 05/24/23 #SocialStocks: Meta fined EUR 1.2B in Ireland for infringing on data laws 05/17/23 #SocialStocks: Tech companies seek employees abroad after hiring freeze 05/15/23 What You Missed On Wall Street On Monday 05/15/23 What You Missed On Wall Street This Morning META Meta Platforms $262.01 / +9.33 (+3.69%) 05/24/23 What You Missed On Wall Street On Wednesday 05/24/23 #SocialStocks: Meta fined EUR 1.2B in Ireland for infringing on data laws 05/24/23 What You Missed On Wall Street This Morning 05/23/23 What You Missed On Wall Street On Tuesday 06/14/23 2023 Semiconductor Bus Tour 06/01/23 Broadcom - AVGO 05/31/23 Meta Platforms Inc 06/02/23 Alphabet Inc. CL A 06/02/23 Alphabet Inc. CL C AVGO GOOG GOOGL META AVGO Broadcom $812.72 / +84.07 (+11.54%) 05/26/23 Early notable gainers among liquid option names on May 26th 03/03/23 Early notable gainers among liquid option names on March 3rd 03/02/23 Broadcom options imply 2.8% move in share price post-earnings 01/10/23 Unusually active option classes on open January 10th GOOG Alphabet $125.37 / +1.04 (+0.84%) 05/11/23 Unusually active option classes on open May 11th 04/25/23 Alphabet options imply 4.8% move in share price post-earnings 03/16/23 Alphabet call buyer realizes 17% same-day gains 02/28/23 Notable open interest changes for February 28th GOOGL Alphabet $124.62 / +1.14 (+0.92%) 05/22/23 Notable open interest changes for May 22nd 05/16/23 Early notable gainers among liquid option names on May 16th 05/15/23 Unusually active option classes on open May 15th 05/15/23 Notable open interest changes for May 15th META Meta Platforms $262.01 / +9.33 (+3.69%) 05/22/23 Early notable gainers among liquid option names on May 22nd 04/28/23 Notable open interest changes for April 28th 04/27/23 Early notable gainers among liquid option names on April 27th 04/27/23 Notable open interest changes for April 27th
Hot Stocks	Pfizer's marstacimab shows significant efficacy in Phase 3 hemophilia trial » 06:49 05/30/23 05/30 06:49 05/30/23 06:49 PFE Pfizer $37.59 / -0.245 (-0.65%) Pfizer announced that the… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return on Jun 2nd, 06:49 Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options PFE Pfizer $37.59 / -0.245 (-0.65%) 05/26/23 Pfizer, BioNTech in agreement with EU to reduce COVID vaccine volumes 05/25/23 Pfizer confirms FDA approves Paxlovid for mild-to-moderate COVID-19 in adults 05/25/23 FDA approves Paxlovid for mild-to-moderate COVID-19 in adults 05/23/23 Moderna, BioNTech other Covid vaccine makers jump amid China Covid scare PFE Pfizer $37.59 / -0.245 (-0.65%) 05/23/23 Jefferies Jefferies says Pfizer oral GLP-1 safety and tolerability 'important to note' 05/22/23 Pfizer weight loss drug may be as effective, quicker than Ozempic, CNBC says 05/19/23 BofA AdComm support for Pfizer's infant RSV vaccine 'not surprising,' says BofA 05/16/23 Stifel Seagen likely to stay 'distanced' from deal price after FTC action, says Stifel PFE Pfizer $37.59 / -0.245 (-0.65%) 05/02/23 Pfizer backs FY23 adjusted EPS view $3.25-$3.45, consensus $3.36 05/02/23 Pfizer reports Q1 adjusted EPS $1.23, consensus 98c 03/15/23 Royalty Pharma raises FY23 adjusted cash receipt guidance to $2.85B-$2.95B 01/31/23 Pfizer sees FY23 adjusted EPS $3.25-$3.45, consensus $4.44 PFE Pfizer $37.59 / -0.245 (-0.65%) 05/26/23 Health authorities to target next COVID shot to new strain, WSJ says 05/23/23 China's new Covid surge could result in 65M infections a week, Bloomberg says 05/14/23 Pfizer Pfizer, Stryker have strong growth prospects, Barron's says 05/10/23 BioNTech pancreatic cancer vaccine 'shows promise' in small trial, NYT says PFE Pfizer $37.59 / -0.245 (-0.65%) 05/16/23 What You Missed On Wall Street On Tuesday 05/02/23 What You Missed On Wall Street On Tuesday 05/02/23 What You Missed On Wall Street This Morning 03/21/23 What You Missed On Wall Street On Tuesday 06/28/23 Biotech/Biopharma 06/28/23 Biotech/Biopharma 06/02/23 2023 ASCO Annual Meeting 06/02/23 Truist Hosted Company Events at 2023 ASCO Annual Meeting PFE Pfizer $37.59 / -0.245 (-0.65%) 05/24/23 Notable open interest changes for May 24th 05/23/23 Unusually active option classes on open May 23rd 05/23/23 Notable open interest changes for May 23rd 05/23/23 Unusual call flow in option market yesterday
Initiation	Baxter assumed with an Equal Weight at Morgan Stanley » 06:48 05/30/23 05/30 06:48 05/30/23 06:48 BAX Baxter $41.29 / -0.055 (-0.13%) Morgan Stanley assumed… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return on Jun 2nd, 06:48 Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options BAX Baxter $41.29 / -0.055 (-0.13%) 05/23/23 Artivion's PerClot system granted FDA Premarket Application approval 05/09/23 GE HealthCare names James Saccaro as CFO 05/09/23 Baxter CFO Jay Saccaro leaving at end of May, Brian Stevens named interim 05/08/23 Baxter trading resumes BAX Baxter $41.29 / -0.055 (-0.13%) 05/01/23 Barclays Baxter price target raised to $58 from $54 at Barclays 04/28/23 Stifel Baxter price target raised to $54 from $45 at Stifel 04/28/23 Deutsche Bank Baxter price target raised to $50 from $40 at Deutsche Bank 04/28/23 TD Cowen Baxter price target raised to $50 from $45 at TD Cowen BAX Baxter $41.29 / -0.055 (-0.13%) 04/27/23 Baxter sees Q2 EPS 59c- 61c, consensus 60c 04/27/23 Baxter reports Q1 EPS 59c, consensus 49c 04/26/23 Notable companies reporting before tomorrow's open 04/26/23 Notable companies reporting before tomorrow's open BAX Baxter $41.29 / -0.055 (-0.13%) 05/08/23 Warburg, Advent in lead to acquire Baxter's biopharma unit, Reuters says 03/20/23 Thermo Fisher, Celltrion compete for Baxter's biopharma unit, Reuters says BAX Baxter $41.29 / -0.055 (-0.13%) 04/27/23 Fly Intel: Pre-market Movers 03/21/23 What You Missed On Wall Street On Tuesday 03/21/23 What You Missed On Wall Street This Morning 02/09/23 Fly Intel: Pre-market Movers BAX Baxter $41.29 / -0.055 (-0.13%) 05/22/23 Unusually active option classes on open May 22nd 02/21/23 Baxter call volume above normal and directionally bullish 02/09/23 Baxter put volume heavy and directionally bearish 01/24/23 Baxter put volume heavy and directionally bearish
Initiation	Becton Dickinson assumed with an Overweight at Morgan Stanley » 06:48 05/30/23 05/30 06:48 05/30/23 06:48 BDX Becton Dickinson $241.13 / -0.49 (-0.20%) Morgan Stanley analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return on Jun 2nd, 06:48 Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly BDX Becton Dickinson $241.13 / -0.49 (-0.20%) 05/16/23 Becton Dickinson announces FDA clearance for BD Kiestra MRSA imaging application 04/03/23 Becton Dickinson names Michelle Quinn as general counsel 03/16/23 Becton Dickinson receives FDA clearance for BD Vaginal Panel 03/09/23 Moody's to appoint Vincent Forlenza chairman on April 18 BDX Becton Dickinson $241.13 / -0.49 (-0.20%) 05/08/23 Barclays Becton Dickinson price target raised to $284 from $282 at Barclays 05/05/23 Piper Sandler Becton Dickinson upgraded to Overweight after pullback at Piper Sandler 05/05/23 Piper Sandler Becton Dickinson upgraded to Overweight from Neutral at Piper Sandler 04/12/23 KeyBanc Becton Dickinson upgraded to Overweight from Sector Weight at KeyBanc BDX Becton Dickinson $241.13 / -0.49 (-0.20%) 05/04/23 Becton Dickinson ups FY23 adjusted EPS view to $12.10-$12.32 from $12.07-$12.32 05/04/23 Becton Dickinson reports Q2 EPS $2.86, consensus $2.74 02/02/23 Becton Dickinson ups FY23 adjusted EPS view to $12.07-$12.32 from $11.85-$12.10 02/02/23 Becton Dickinson reports Q1 adjusted EPS $2.98, consensus $2.68 BDX Becton Dickinson $241.13 / -0.49 (-0.20%) 05/05/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 04/12/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 01/03/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 12/12/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
Hot Stocks	Team regains NYSE compliance » 06:47 05/30/23 05/30 06:47 05/30/23 06:47 TISI Team $8.10 / +1.08 (+15.38%) Team announced that it… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return on Jun 2nd, 06:47 Get Free Trial ShowHide Related Items >><< Company News TISI Team $8.10 / +1.08 (+15.38%) 05/25/23 Team secures stakeholder loans to refinance capital structure 12/21/22 Team completes one-for-ten reverse stock split 12/09/22 Team announces one-for-ten reverse stock split
Hot Stocks	Golden Minerals to effect 1-for-25 reverse stock split » 06:46 05/30/23 05/30 06:46 05/30/23 06:46 AUMN Golden Minerals / + Golden Minerals announced… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return on Jun 2nd, 06:46 Get Free Trial ShowHide Related Items >><< Company News Street Research AUMN Golden Minerals / + 04/18/23 Golden Minerals reports Q1 production from Rodeo mine 04/04/23 Golden Minerals announces improved terms for Velardena Properties concentrates 01/11/23 Golden Minerals reports Q4 payable gold production 2,398 oz Au AUMN Golden Minerals / + 03/24/23 Alliance Global Partners Golden Minerals price target lowered to 80c from $1.10 at Alliance Global 08/04/22 H.C. Wainwright Golden Minerals price target lowered to 60c from $1 at H.C. Wainwright

Recommendations	PayPal recent weakness should be bought, says Mizuho » 06:45 05/30/23 05/30 06:45 05/30/23 06:45 PYPL PayPal $60.22 / +0.835 (+1.41%) Mizuho analyst Dan Dolev… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return on Jun 2nd, 06:45 Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options PYPL PayPal $60.22 / +0.835 (+1.41%) 05/22/23 Venmo introduces Venmo Teen Account 05/08/23 PayPal reduces FY23 operating margin expansion view to 100bps from 125bps 05/08/23 PayPal CEO says still see many challenging issues 05/08/23 PayPal down 2% despite 'beat and raise' report PYPL PayPal $60.22 / +0.835 (+1.41%) 05/22/23 Bernstein PayPal price target lowered to $70 from $85 at Bernstein 05/19/23 Morgan Stanley Morgan Stanley says proposed 1099-K legislation 'incremental positive' for Block 05/12/23 Exane BNP Paribas PayPal downgraded to Neutral from Outperform at Exane BNP Paribas 05/11/23 Barclays PayPal price target lowered to $92 from $108 at Barclays PYPL PayPal $60.22 / +0.835 (+1.41%) 05/21/23 Fly Intel: Top five weekend stock stories 05/08/23 PayPal raises FY23 adjusted EPS view to about $4.95, consensus $4.36 05/08/23 PayPal sees Q2 EPS $1.15-$1.17, consensus $1.04 05/08/23 PayPal reports Q1 adjusted EPS $1.17, consensus 98c PYPL PayPal $60.22 / +0.835 (+1.41%) 05/21/23 Fintech should be scared as Apple reaches deeper into pockets, Barron's says 05/17/23 PayPal seeking buyers for Xoom money transfer service, The Information says 03/16/23 Thiel had $50M in Silicon Valley Bank before collapse, FT reports 02/03/23 Appeals court revives CFPB rule over fees for prepaid customers, Reuters says PYPL PayPal $60.22 / +0.835 (+1.41%) 05/17/23 What You Missed On Wall Street On Wednesday 05/17/23 What You Missed On Wall Street This Morning 05/12/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 05/10/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations PYPL PayPal $60.22 / +0.835 (+1.41%) 05/10/23 Notable open interest changes for May 10th 05/08/23 PayPal options imply 6.9% move in share price post-earnings 04/12/23 Early notable gainers among liquid option names on April 12th 03/23/23 Unusually active option classes on open March 23rd
Recommendations	Lantheus selloff on competitor approval overdone, says Mizuho » 06:42 05/30/23 05/30 06:42 05/30/23 06:42 LNTH Lantheus $91.06 / -6.855 (-7.00%) Mizuho views… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return on Jun 2nd, 06:42 Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly LNTH Lantheus $91.06 / -6.855 (-7.00%) 05/23/23 Lantheus announces payment to CVR holders of $1.15 per CVR 04/24/23 Lantheus, Point Biopharma announces FDA grants FTD for 177Lu-PNT2002 03/17/23 Lantheus appoints Paul Blanchfield as president, Dan Niedzwiecki as CAO 02/16/23 Lantheus presents data on piflufolastat F 18 at 2023 ASCO symposium LNTH Lantheus $91.06 / -6.855 (-7.00%) 05/05/23 SVB Securities Lantheus price target raised to $127 from $120 at SVB Securities 05/05/23 Truist Lantheus price target raised to $125 from $115 at Truist 05/05/23 JMP Securities Lantheus price target raised to $130 from $120 at JMP Securities 05/05/23 Mizuho Lantheus price target raised to $125 from $115 at Mizuho LNTH Lantheus $91.06 / -6.855 (-7.00%) 05/04/23 Lantheus sees 2023 adjusted EPS $5.45-$5.70, consensus $4.95 05/04/23 Lantheus sees Q2 adjusted EPS $1.25-$1.33, consensus $1.21 05/04/23 Lantheus reports Q1 adjusted EPS $1.47, consensus $1.26 02/23/23 Lantheus sees FY23 adjusted EPS $4.95 - $5.10, consensus $4.21 LNTH Lantheus $91.06 / -6.855 (-7.00%) 03/08/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 02/23/23 What You Missed On Wall Street On Thursday 02/23/23 What You Missed On Wall Street This Morning
Recommendations	Omega Healthcare price target lowered to $31 from $32 at Mizuho » 06:39 05/30/23 05/30 06:39 05/30/23 06:39 OHI Omega Healthcare $28.34 / +0.25 (+0.89%) Mizuho analyst Vikram… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return on Jun 2nd, 06:39 Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events OHI Omega Healthcare $28.34 / +0.25 (+0.89%) 01/24/23 Omega Healthcare trading resumes 01/24/23 Omega Healthcare trading halted, volatility trading pause 01/09/23 Omega Healthcare sees EBITDA declining in Q1 vs. Q4 OHI Omega Healthcare $28.34 / +0.25 (+0.89%) 05/03/23 Stifel Omega Healthcare price target lowered to $33 from $36 at Stifel 04/19/23 Wells Fargo Omega Healthcare initiated with an Overweight at Wells Fargo 01/13/23 Baird Omega Healthcare price target lowered to $29 from $32 at Baird 01/09/23 Credit Suisse Omega Healthcare downgraded to Underperform from Neutral at Credit Suisse OHI Omega Healthcare $28.34 / +0.25 (+0.89%) 05/02/23 Omega Healthcare reports Q1 adjusted FFO 66c, consensus 60c 02/02/23 Omega Healthcare reports Q4 adjusted FFO 73c, consensus 73c 06/05/23 Omega Healthcare Investors
Recommendations	Ventas price target lowered to $53 from $60 at Mizuho » 06:39 05/30/23 05/30 06:39 05/30/23 06:39 VTR Ventas $42.87 / +0.045 (+0.11%) Mizuho analyst Vikram… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return on Jun 2nd, 06:39 Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings VTR Ventas $42.87 / +0.045 (+0.11%) 04/24/23 Land & Buildings letter to Ventas notes significant NOI underperformance 01/23/23 Ventas names J. Justin Hutchens to additional role of chief investment officer VTR Ventas $42.87 / +0.045 (+0.11%) 04/25/23 Barclays Ventas price target lowered to $55 from $57 at Barclays 04/19/23 Wells Fargo Wells Fargo starts Ventas with Overweight on senior housing growth 04/19/23 Wells Fargo Ventas initiated with an Overweight at Wells Fargo 04/12/23 Credit Suisse Ventas price target lowered to $50 from $51 at Credit Suisse VTR Ventas $42.87 / +0.045 (+0.11%) 05/08/23 Ventas backs FY23 normalized FFO view $2.90-$3.04, consensus $2.96 05/08/23 Ventas reports Q1 normalized FFO 74c, consensus 70c 02/09/23 Ventas sees FY23 normalized FFO $2.90-$3.04, consensus $3.07 02/09/23 Ventas reports Q4 normalized FFO 73c, consensus 72c
Recommendations	Welltower price target lowered to $86 from $91 at Mizuho » 06:38 05/30/23 05/30 06:38 05/30/23 06:38 WELL Welltower $73.54 / -0.07 (-0.10%) Mizuho lowered the… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return on Jun 2nd, 06:38 Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options WELL Welltower $73.54 / -0.07 (-0.10%) 05/08/23 Brookdale Senior Living enters revised agreements with Welltower 05/02/23 Welltower reports SS NOI growth of 23.4% year-over-year in quarter 04/24/23 Land & Buildings letter to Ventas notes significant NOI underperformance 02/15/23 Welltower, Retirement Unlimited announce partnership WELL Welltower $73.54 / -0.07 (-0.10%) 05/24/23 Deutsche Bank Deutsche ups target on 'must-own' Welltower to $84 from $81 05/16/23 RBC Capital Welltower price target raised to $87 from $82 at RBC Capital 04/19/23 Wells Fargo Wells Fargo starts Ventas with Overweight on senior housing growth 04/19/23 Wells Fargo Welltower initiated with an Overweight at Wells Fargo WELL Welltower $73.54 / -0.07 (-0.10%) 05/03/23 Welltower reports Q1 normalized FFO 85c, consensus 82c 05/02/23 Welltower raises normalized FFO view to $3.39-$3.54 from $3.35-$3.53 02/15/23 Welltower sees FY23 normalized FFO $3.35-$3.53, consensus $3.57 02/15/23 Welltower reports Q4 normalized FFO 83c, consensus 82c WELL Welltower $73.54 / -0.07 (-0.10%) 12/07/22 Welltower 'obfuscating its distressed assets,' Hindenburg says in short report 12/07/22 Welltower short report published by Hindenburg Research WELL Welltower $73.54 / -0.07 (-0.10%) 04/11/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 04/05/23 Fly Intel: After-Hours Movers 02/03/23 Sell these stocks now, proven algorithm says 12/07/22 What You Missed On Wall Street On Wednesday WELL Welltower $73.54 / -0.07 (-0.10%) 04/06/23 Early notable gainers among liquid option names on April 6th

Events

Earnings calls, analyst events, roadshows and more

GOTU
Today at 08:00

Gaotu Techedu - GOTU Conference Calls
GLNG
Today at 08:00

Golar LNG - GLNG Conference Calls
BNR
Today at 08:00

Burning Rock Biotech - BNR Conference Calls
TIGR
Today at 08:00

UP Fintech - TIGR Conference Calls
TCRR
Today at 08:00

TCR2 Therapeutics Inc. Firm Sponsored Meetings
MDWD
Today at 08:30

MediWound - MDWD Conference Calls
YTRA
Today at 08:30

Yatra - YTRA Conference Calls
Today at 09:00

Case-Shiller Home Price Index: 20-City Adjusted M/M: March 2023 Government Event
Today at 09:00

Case-Shiller Home Price Index: 20-City Unadjusted M/M: March 2023 Government Event
Today at 09:00

Case-Shiller Home Price Index: 20-City Unadjusted Y/Y: March 2023 Government Event

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	No deals
Tues	No deals
Wed	No deals
Thurs	No deals
Fri	No deals

Mon	No deals
Tues	No deals
Wed	AZTR X AZTR Azitra IPO Managers: ThinkEquity $4.50-5.50 2.4M Shares SXTP X SXTP 60 Degrees Pharmaceuticals IPO Managers: WallachBeth $4.30-6.30 1.415M Shares
Thurs	No deals
Fri	No deals

View All Syndicate Announcements »

Assertio provides the LGS Foundation $100,000 educational grant

OTHER BREAKING NEWS FROM THE FLY

Get Full Fly Access